Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Geneva Biotech TEMTAC™

Intelligent DNA delivery systems

Welcome Guest \\ Login

TEMTAC™

Technology Description

Understanding the quantitative functional consequences of human disease mutations requires silencing of endogenous genes and expression of mutants at close to physiological levels. Changing protein levels above or below these levels is also important for system perturbation and modelling. Fast design optimization demands flexible interchangeable cassettes for endogenous gene silencing and tuneable expression. ‘TEMTAC’ is a multigene recombineering and delivery system for simultaneous siRNA-based knockdown and regulated mutant (or other variant) expression with different dynamic ranges.

Downloads and References:

Click here to download Beltran-Sastre et al 2015. Nature Scientific Reports.

Kits

TEMTAC™ Expression System Kit 1,149.00€ ENQUIRY

Enquiry

E.coli cell expression
MultiColi™

Research Highlights

our r&d View all

Latest News

GENEVA BIOTECH CO-FOUNDERS PUBLISH IN SCIENCE GOOD REVIEW IN FORBES Geneva Biotech co-founders publish in Science good review in Forbes ...

View all

    Contact Us